CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure Angiotensin–neprilysin inhibition versus enalapril in heart failure Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes 3D Printing and Heart Failure: The Present and the Future

Clinical Trial2018 Apr 12;378(15):1386-1395.

JOURNAL:N Engl J Med. Article Link

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

Mehra MR, Goldstein DJ, MOMENTUM 3 Investigators. Keywords: Magnetically Levitated Left Ventricular Assist Device; heart failure; pump thrombosis;

FULL TEXT PDF